Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-13 of 13 for your search:
Drug:
sodium phenylbutyrate
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Patients With Advanced Colorectal Adenocarcinoma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MTS-96322-ME
, NCI-T96-0015O, NCT00002796, T96-0015
2.
Phase II Pilot Study of Phenylbutyrate Plus Azacytidine in Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-99060
, NCI-T99-0091, NCT00006019, T99-0091
3.
Phase II Study of Phenylbutyrate in Pediatric Patients With Progressive or Recurrent CNS Malignancy
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
TCCC-H-6321
, TCCC-GCRC-0692, NCI-O1-C-0028, NCI-T98-0042, NCT00006238, T98-0042
4.
Phase I Study of Twice-Daily Intravenous Phenylbutyrate for Advanced Cancer (Summary Last Modified 06/98)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
MSKCC-94111
, NCI-T94-0170D, T94-0170
5.
Phase I Study of Phenylbutyrate as a 120-Hour Infusion in Refractory Solid Tumors (Summary Last Modified 05/1999)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-9502
, NCI-T94-0097D, T94-0097
6.
Phase I Study of Phenylbutyrate for Myelodysplastic Syndrome and Relapsed Acute Myeloid Leukemia (Summary Last Modified 10/1999)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
JHOC-9446
, NCI-T94-0196D, T94-0196
7.
Phase I Study of Phenylbutyrate in Children with Refractory Malignancies (Summary Last Modified 07/1999)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
TCCC-T96-0044
, NCI-T96-0044O, T96-0044
8.
Phase I and Pharmacokinetic Study of Phenylbutyrate in Pediatric Patients With Refractory Cancer (Summary Last Modified 01/2001)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
2-21
Sponsor:
NCI
Protocol IDs:
NCI-97-C-0051G
, BCM-H5292, NCI-T96-0044
9.
Phase I Study of Phenylbutyrate Plus Tretinoin in Patients With Acute Promyelocytic Leukemia, Neuroblastoma, Non-Small Cell Lung Cancer, or Prostate Cancer (Summary Last Modified 04/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
MSKCC-98081
, NCI-T98-0043, T98-0043
10.
Phase I Study of Azacitidine in Combination With Phenylbutyrate in Patients With Recurrent, Refractory, or Untreated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-99072307
, NCI-T99-0092, NCT00004871, T99-0092, JHOC-J9950
11.
Phase I Study of Azacitidine and Phenylbutyrate in Patients With Refractory Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-99120302
, JHOC-J9982, NCI-270, NCT00005639, 270
12.
Phase I Study of Phenylbutyrate and Tretinoin in Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J9879
, JHOC-99072306, NCI-T98-0068, NCT00006239, T98-0068
13.
Phase I Study of Phenylbutyrate by Continuous Infusion in Patients with Cancer
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
NCI-93-C-0090L
, NCI-CPB-307
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute